Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Taking Care Of Business Before J.P. Morgan

Jan 06 2017

• By Joseph Haas, Ying Huang, Emily Hayes, and Lubna Ahmed

US dollars

Related Content

Copaxone’s Tombstone? 2014 Could Be Year Generic Launches, Momenta Says

Feb 17 2014

Sandoz/Momenta’s Copaxone Generic Clears FDA, But Court Action May Guide Launch Timing

Apr 16 2015

Ex-GSK China researchers hit back

Jun 20 2013

Finding Cutting-Edge Science Takes A Broad Net, J&J Innovation’s Urban Says

Jan 05 2017

J&J Innovation’s Latest Deal Spree Includes CB-1 Antibody For NASH

Jan 05 2017

Novartis Spreads Cardiovascular Bets with Ionis Antisense Option Deal

Jan 06 2017

Takeda Funds Celiac Asset As Prelude To Potential Acquisition

Jan 06 2017

Is It The End For OncoGenex? Custirsen Fails In Second Phase III Prostate Cancer Trial

Aug 17 2016

Obesity Market Snapshot: Marketing Partners Giving Obesity The Slow Goodbye

May 09 2016

Related Companies

Momenta Pharmaceuticals, Inc.

CSL Limited

Novartis AG

Teva Pharmaceutical Industries Ltd.

Takeda Pharmaceutical Co. Ltd.

Grifols, S.A.

Pieris Pharmaceuticals, Inc.

Les Laboratoires Servier

Arena Pharmaceuticals, Inc.

Eisai Co., Ltd.

Orexigen Therapeutics, Inc.

Vivus, Inc.

Translate Bio

Takeda Pharmaceutical Co. Ltd.

AstraZeneca PLC

APT Therapeutics Inc.

Achieve Life Sciences, Inc.

AbCellera Biologics Inc.

Pfizer Inc.

Ferring Pharmaceuticals

GSK plc

Johnson & Johnson

Johnson & Johnson

Novartis AG

Ionis Pharmaceuticals, Inc.

Takeda Pharmaceutical Co. Ltd.

Additional Topics

Deals Business Strategies M & A Commercial BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window